2017 - Member of Academia Europaea
The scientist’s investigation covers issues in Immunology, Vaccination, Streptococcus pneumoniae, Virology and Conjugate vaccine. His work on Immunology is being expanded to include thematically relevant topics such as Meningococcal disease. The various areas that David Goldblatt examines in his Vaccination study include Immunization, Pediatrics and Antibody titer.
His Streptococcus pneumoniae research incorporates themes from Carriage, Serotype, Microbiology and Antigen. While the research belongs to areas of Virology, David Goldblatt spends his time largely on the problem of Haemophilus influenzae, intersecting his research to questions surrounding Whooping cough. David Goldblatt combines subjects such as Pneumococcal conjugate vaccine and Licensure with his study of Conjugate vaccine.
David Goldblatt mainly focuses on Immunology, Vaccination, Antibody, Virology and Streptococcus pneumoniae. Much of his study explores Immunology relationship to Pneumococcal conjugate vaccine. David Goldblatt focuses mostly in the field of Pneumococcal conjugate vaccine, narrowing it down to topics relating to Pediatrics and, in certain cases, Pneumonia, Incidence and Chronic granulomatous disease.
David Goldblatt has researched Vaccination in several fields, including Immunization, Haemophilus influenzae and Meningococcal disease. His Antibody research is multidisciplinary, incorporating elements of Immunity and Antigen. His Streptococcus pneumoniae study combines topics in areas such as Carriage and Colonisation, Colonization, Microbiology.
David Goldblatt mostly deals with Immunology, Antibody, Streptococcus pneumoniae, Vaccination and Pneumococcal conjugate vaccine. The concepts of his Antibody study are interwoven with issues in Severe acute respiratory syndrome coronavirus 2, Immunity, Antigen and Virology. His Streptococcus pneumoniae research integrates issues from Colonisation and Microbiology.
In his study, Routine vaccination, Incidence and Pneumococcal infections is strongly linked to Carriage, which falls under the umbrella field of Vaccination. He interconnects Booster dose, Internal medicine, Randomized controlled trial, Immunogenicity and Pediatrics in the investigation of issues within Pneumococcal conjugate vaccine. His Pediatrics research is multidisciplinary, relying on both Tetanus and Diphtheria.
David Goldblatt spends much of his time researching Immunology, Antibody, Vaccination, Streptococcus pneumoniae and Antigen. His work carried out in the field of Immunology brings together such families of science as Streptococcus vaccine and Disease. His Antibody research incorporates elements of Streptococcus, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019 and Immunity.
His work on Influenza vaccine is typically connected to Pneumococcal polysaccharide vaccine as part of general Vaccination study, connecting several disciplines of science. His Streptococcus pneumoniae research is multidisciplinary, incorporating perspectives in Internal medicine, Microbiology and Serum samples. His biological study spans a wide range of topics, including Virology, Pneumococcal vaccine, Adverse effect, Polysaccharide and Pneumococcal conjugate vaccine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
Marie Scully;Deepak Singh;Robert Lown;Anthony Poles.
The New England Journal of Medicine (2021)
The fundamental link between pneumococcal carriage and disease
Birgit Simell;Kari Auranen;Helena Käyhty;David Goldblatt.
Expert Review of Vaccines (2012)
Evidence for antibody as a protective correlate for COVID-19 vaccines
Kristen A. Earle;Donna M. Ambrosino;Andrew Fiore-Gartland;David Goldblatt.
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
Nick J Andrews;Pauline A Waight;Polly Burbidge;Emma Pearce.
Lancet Infectious Diseases (2014)
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
Luis Jódar;Jay Butler;George Carlone;Ron Dagan.
Dense genomic sampling identifies highways of pneumococcal recombination
Claire Chewapreecha;Simon R Harris;Nicholas J Croucher;Claudia Turner;Claudia Turner;Claudia Turner.
Nature Genetics (2014)
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.
Ray Borrow;Nick Andrews;David Goldblatt;Elizabeth Miller.
Infection and Immunity (2001)
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
Catherine M. Wernette;Carl E. Frasch;Dace Madore;George Carlone.
Clinical and Vaccine Immunology (2003)
Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study
Lisa M McNally;Lisa M McNally;Prakash M Jeena;Kavitha Gajee;Stanley A Thula.
The Lancet (2007)
Antibody Responses to Nasopharyngeal Carriage of Streptococcus pneumoniae in Adults: A Longitudinal Household Study
David Goldblatt;Mahein Hussain;Nicholas Andrews;Lindsey Ashton.
The Journal of Infectious Diseases (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: